Home > National Drug Code (NDC) > Sheffield Triple Antibiotic

Sheffield Triple Antibiotic - 11527-162-51 - (Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate)

Alphabetical Index


Drug Information of Sheffield Triple Antibiotic

Product NDC: 11527-162
Proprietary Name: Sheffield Triple Antibiotic
Non Proprietary Name: Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate
Active Ingredient(s): 400; 3.5; 5000    [USP'U]/g; mg/g; [USP'U]/g & nbsp;   Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate
Administration Route(s): TOPICAL
Dosage Form(s): OINTMENT
Coding System: National Drug Codes(NDC)

Labeler Information of Sheffield Triple Antibiotic

Product NDC: 11527-162
Labeler Name: Faria LLC dba Sheffield Pharmaceuticals
Product Type: HUMAN OTC DRUG
FDA Application Number: part333B
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20110123

Package Information of Sheffield Triple Antibiotic

Package NDC: 11527-162-51
Package Description: 1 TUBE in 1 CARTON (11527-162-51) > 14 g in 1 TUBE

NDC Information of Sheffield Triple Antibiotic

NDC Code 11527-162-51
Proprietary Name Sheffield Triple Antibiotic
Package Description 1 TUBE in 1 CARTON (11527-162-51) > 14 g in 1 TUBE
Product NDC 11527-162
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate
Dosage Form Name OINTMENT
Route Name TOPICAL
Start Marketing Date 20110123
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Faria LLC dba Sheffield Pharmaceuticals
Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength Number 400; 3.5; 5000
Strength Unit [USP'U]/g; mg/g; [USP'U]/g
Pharmaceutical Classes

Complete Information of Sheffield Triple Antibiotic


General Information